BERKELEY, Calif. & FAIRHOPE, Ala.–(BUSINESS WIRE)– #colorishere–EnChroma lens technology for color blindness is available in scenic viewers made by SeeCoast, enabling the color blind to enjoy the colors of nature.
Category: Business
Aurinia Prices US$166.7 Million Public Offering of Common Shares
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced th…
Global Glaucoma Surgery Devices Market 2019-2023| Evolving Opportunities with ALLERGAN and Carl Zeiss Meditec | Technavio
LONDON–(BUSINESS WIRE)– #glaucomasurgerydevices–Technavio has been monitoring the global glaucoma surgery devices market since 2016 and the market is poised to grow by USD 1 billion during 2019-2023
Global Optic Neuropathy Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. The review provi…
Canon Inc. Realigns Strategy to Prepare for Eye Care Systems Business Growth
TUSTIN, Calif.–(BUSINESS WIRE)–As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A. Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020. Canon’s shift …
Aerie Pharmaceuticals Announces Appointment of Amine Sinmazisik as Director, Finance
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Global Cataract Surgery Devices and Equipment Market Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global cataract surgery devices and equipment market was valued at about $3.4 billion in 201…
Opportunities in Global Ophthalmic Surgery Markets, 2019 & Beyond – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Opportunities in Global Ophthalmic Surgery Markets” report has been added to ResearchAndMarkets.com’s offering. Coverage in this report includes a detailed analysis of the current and forecast markets for ophthalmic surger…
Vivior e SwissLens danno vita a un partenariato per lo sviluppo di lenti a contatto personalizzate
ZURIGO–(BUSINESS WIRE)–Le due società elvetiche accettano di collaborare nel campo della correzione della presbiopia tramite lenti a contatto morbide multifocali personalizzate, nell’obiettivo di ottimizzarne la progettazione utilizzando i dati gener…
Chris R. Stark Joins EyeCare Services Partners as Vice President, Managed Care
DALLAS–(BUSINESS WIRE)–EyeCare Services Partners (ESP), the national leader in integrated eye care services, announced today that Chris R. Stark recently joined the Company as Vice President, Managed Care. Mr. Stark is responsible for the firm’s cont…
Metrion Biosciences and LifeArc Extend Ion Channel Drug Discovery Collaboration to Accelerate Neuroscience-focused Research
CAMBRIDGE, England & LONDON–(BUSINESS WIRE)–Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuros…
Vivior en SwissLens werken samen voor de ontwikkeling van gepersonaliseerde contactlenzen
ZURICH–(BUSINESS WIRE)–Beide Zwitserse bedrijven kwamen overeen samen te gaan werken op het gebied van gepersonaliseerde multifocale zachte contactlenzen voor presbyopiecorrectie. Het doel is om het ontwerp van zachte multifocale contactlenzen te opt…
Aldeyra Therapeutics to Host Conference Call and Webcast to Announce Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Tuesday, December 3, 2019, to provide top-line results from Part 1 of the adaptive Phase 3 RENEW Trial of top…
Resumen: Vivior y SwissLens establecen una colaboración para el desarrollo de lentes de contacto personalizadas
ZURICH–(BUSINESS WIRE)–Ambas compañías suizas acordaron colaborar en el campo de las lentes de contacto blandas multifocales personalizadas para la corrección de la presbicia. El objetivo es optimizar el diseño de las lentes de contacto blandas multi…
Vivior and SwissLens establish collaboration for the development of personalized contact lenses
ZURICH–(BUSINESS WIRE)–Both Swiss companies agreed to collaborate in the field of personalized multifocal soft contact lenses for presbyopia correction. The objective is to optimize the design in soft multifocal contact lenses by using the data gener…
NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova®, on Amazon.com. Avenova Direct, NovaBay’s prescript…
Positive Phase III Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum Disorder Published in the New England Journal of Medicine
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that data from SAkuraSky, a pivotal Phase III study of the investigational medicine satralizumab for the treatment of neu…
ジーエヌコーポレーション：ナノシート手法を使用した角膜細胞移植で視力を回復、日本企業がインドで特許を交付される
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — 水疱性角膜症などの角膜内皮疾患をナノ複合ゲルシートで治療するための新規細胞移植手法を日本の科学者らが開発し、日本のジーエヌコーポレーション（GNC）にインド特許が交付されました。この手法は既に日本特許として交付されており、1人の死体ドナー角膜に由来する細胞がラボ培養した角膜内皮細胞前駆細胞を使用することで、患者数人の視力を救うことに使用できるものです。 白内障手術中の不注意な外科手術などに起因する外傷による角膜内皮疾患は毎年、インド…
GN CORPORATION: Visão restaurada com transplante de células da córnea usando uma técnica com folha de nanocomposto; empresa japonesa recebe patente na Índia
TÓQUIO–(BUSINESS WIRE)–Um novo método de transplante de células para tratar doenças endoteliais da córnea, como ceratopatia bolhosa, usando uma folha de nanocomposto de gel desenvolvida por cientistas japoneses, recebeu a patente indiana da GN Corpor…
GN CORPORATION : Restauration de la vue au moyen d’une greffe de cellules cornéennes réalisée à l’aide d’une technique de nanofeuilles : la société japonaise se voit accorder un brevet en Inde
TOKYO–(BUSINESS WIRE)–GN Corporation (GNC), au Japon, s’est vue octroyer un brevet indien pour une nouvelle méthode de transplantation cellulaire destinée à traiter les maladies des cellules endothéliales de la cornée, telles que la kératopathie bull…